Fibroblast Growth Factor Receptor 4

Mapping Intimacies ◽

10.32388/xtxa2z ◽

2020 ◽

Author(s):

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth

Get full-text (via PubEx)

Faculty Opinions recommendation of Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1014779.194603 ◽

2003 ◽

Author(s):

Sjur Olsnes

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Receptor Signalling

Get full-text (via PubEx)

Faculty Opinions recommendation of The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1022433.254707 ◽

2004 ◽

Author(s):

Kermit Carraway

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Kinase Activity ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Receptor Trafficking ◽

Activation Loop ◽

Fibroblast Growth

Get full-text (via PubEx)

Faculty Opinions recommendation of Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1026857.327437 ◽

2005 ◽

Author(s):

Sjur Olsnes

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth

Get full-text (via PubEx)

Faculty Opinions recommendation of Spatiotemporal control of fibroblast growth factor receptor signals by blue light.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718475804.793499467 ◽

2014 ◽

Author(s):

Simon Cook ◽

Hannah Johnson

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Blue Light ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Spatiotemporal Control

Get full-text (via PubEx)

Disruption of Fibroblast Growth Factor Receptor (FGFR) Signaling as an Approach to Prostate Cancer Therapy

10.21236/ada455329 ◽

2006 ◽

Author(s):

Mustafa Ozen

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Therapy ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Prostate Cancer Therapy ◽

Fgfr Signaling

Get full-text (via PubEx)

Fibroblast Growth Factor Receptor Inhibitors

Current Pharmaceutical Design ◽

10.2174/13816128130409 ◽

2012 ◽

Vol 19 (4) ◽

pp. 687-701

Author(s):

Suneel Kumar B.V.S ◽

Lakshmi Narasu ◽

Rambabu Gundla ◽

Raveendra Dayam ◽

Sarma J.A.R.P

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth

Get full-text (via PubEx)

Molecular Modeling, de novo Design and Synthesis of a Novel, Extracellular Binding Fibroblast Growth Factor Receptor 2 Inhibitor Alofanib (RPT835)

Medicinal Chemistry ◽

10.2174/1573406412666160106154726 ◽

2016 ◽

Vol 12 (4) ◽

pp. 303-317 ◽

Cited By ~ 6

Author(s):

Ilya Tsimafeyeu ◽

Frits Daeyaert ◽

Jean-Baptiste Joos ◽

Koen V. Aken ◽

John Ludes-Meyers ◽

...

Keyword(s):

Molecular Modeling ◽

Growth Factor ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

De Novo ◽

Growth Factor Receptor ◽

De Novo Design ◽

Fibroblast Growth ◽

Design And Synthesis

Get full-text (via PubEx)

Enhanced Expression of Fibroblast Growth Factor Receptor 3 in Human Skin Cancer Cells

The Open Circulation & Vascular Journal ◽

10.2174/1877382600902010030 ◽

2009 ◽

Vol 2 (1) ◽

pp. 30-36 ◽

Cited By ~ 2

Author(s):

Motoki Terada ◽

Chikara Ohnishi ◽

Nobuhiro Ueno ◽

Akio Shimizu ◽

Michiyuki Kanai ◽

...

Keyword(s):

Growth Factor ◽

Skin Cancer ◽

Cancer Cells ◽

Fibroblast Growth Factor ◽

Human Skin ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Enhanced Expression

Get full-text (via PubEx)

Primary and Secondary Dimer Interfaces of the Fibroblast Growth Factor Receptor 3 Transmembrane Domain: Characterization via Multiscale Molecular Dynamics Simulations

Biochemistry ◽

10.1021/bi401576k ◽

2014 ◽

Vol 53 (2) ◽

pp. 323-332 ◽

Cited By ~ 18

Author(s):

Tyler Reddy ◽

Santiago Manrique ◽

Amanda Buyan ◽

Benjamin A. Hall ◽

Alan Chetwynd ◽

...

Keyword(s):

Molecular Dynamics ◽

Growth Factor ◽

Molecular Dynamics Simulations ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Transmembrane Domain ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Dynamics Simulations

Get full-text (via PubEx)

Fibroblast Growth Factor Receptor Inhibitor–Associated Multifocal Serous Retinal Detachments: A Case Report

Journal of VitreoRetinal Diseases ◽

10.1177/24741264211013629 ◽

2021 ◽

pp. 247412642110136

Author(s):

Diana H. Kim ◽

Tian Xia ◽

Peter Bracha ◽

Brian L. VanderBeek

Keyword(s):

Case Report ◽

Growth Factor ◽

Urothelial Carcinoma ◽

Fibroblast Growth Factor ◽

Fibroblast Growth Factor Receptor ◽

Growth Factor Receptor ◽

Fibroblast Growth ◽

Metastatic Urothelial Carcinoma ◽

Optical Coherence Tomography Imaging ◽

Receptor Inhibitor

Purpose: This report aims to describe a case of bilateral, multifocal neurosensory retinal detachments that developed during erdafitinib therapy for metastatic urothelial carcinoma. Methods: A case report with color fundus imaging and spectral-domain optical coherence tomography imaging is presented. Results: A 50-year-old man with metastatic urothelial carcinoma had an unremarkable baseline ophthalmic examination prior to starting erdafitinib. At 3-month follow up, an examination revealed bilateral, multifocal retinal detachments. Because the patient was asymptomatic and erdafitinib was the only drug to which his tumor had responded, he was kept on the medication with close ophthalmic monitoring. Conclusions: Erdafitinib, a fibroblast growth factor receptor inhibitor, can cause bilateral, multifocal retinal detachments. Continuation of erdafitinib may be considered in patients without significant visual impairment when the overall benefit of the medication appears to outweigh the risks.

Get full-text (via PubEx)